StockData
Enveric Biosciences, Inc. logo

Enveric Biosciences, Inc. (ENVB) stock

ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.44−0.07 (-4.95%)

Close on Nov 16, 2026Market cap $6.45MP/E –Yield –

Enveric Biosciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Enveric Biosciences

Enveric Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Enveric Biosciences figures

See a number that looks wrong?